Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study

<p>Abstract</p> <p>Background</p> <p>Non-invasive surrogate measures which are valid and responsive to change are needed to study cardiovascular risks in HIV. We compared the construct validity of two noninvasive arterial measures: carotid intima medial thickness (IMT),...

Full description

Bibliographic Details
Main Authors: Thabane Lehana, Smieja Marek, Odueyungbo Adefowope, Smaill Fiona, Gough Kevin, Gill John, Anderson Todd, Elston Dawn, Smith Sandy, Beyene Joseph, Lonn Eva
Format: Article
Language:English
Published: BMC 2009-06-01
Series:AIDS Research and Therapy
Online Access:http://www.aidsrestherapy.com/content/6/1/11
id doaj-d2460891825c4634a3b5953f0683c21f
record_format Article
spelling doaj-d2460891825c4634a3b5953f0683c21f2020-11-25T00:01:48ZengBMCAIDS Research and Therapy1742-64052009-06-01611110.1186/1742-6405-6-11Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort studyThabane LehanaSmieja MarekOdueyungbo AdefowopeSmaill FionaGough KevinGill JohnAnderson ToddElston DawnSmith SandyBeyene JosephLonn Eva<p>Abstract</p> <p>Background</p> <p>Non-invasive surrogate measures which are valid and responsive to change are needed to study cardiovascular risks in HIV. We compared the construct validity of two noninvasive arterial measures: carotid intima medial thickness (IMT), which measures anatomic disease; and brachial flow-mediated vasodilation (FMD), a measure of endothelial dysfunction.</p> <p>Methods</p> <p>A sample of 257 subjects aged 35 years or older, attending clinics in five Canadian centres, were prospectively recruited into a study of cardiovascular risk among HIV subjects. The relationship between baseline IMT or FMD and traditional vascular risk factors was studied using regression analysis. We analyzed the relationship between progression of IMT or FMD and risk factors using fixed-effects models. We adjusted for use of statin medication and CD4 count in both models.</p> <p>Results</p> <p>Baseline IMT was significantly associated with age (p < 0.001), male gender (p = 0.034), current smoking status (p < 0.001), systolic blood pressure (p < 0.001) and total:HDL cholesterol ratio (p = 0.004), but not statin use (p = 0.904) and CD4 count (p = 0.929). IMT progression was significantly associated with age (p < 0.001), male gender (p = 0.0051) and current smoking status (p = 0.011), but not statin use (p = 0.289) and CD4 count (p = 0.927). FMD progression was significantly associated with current statin use (p = 0.019), but not CD4 count (p = 0.84). Neither extent nor progression of FMD was significantly associated with any of the examined vascular risk factors.</p> <p>Conclusion</p> <p>IMT correlates better than FMD with established cardiovascular risk factors in this cohort of HIV patients. Standardization of protocols for FMD and IMT will facilitate the comparison of results across studies.</p> http://www.aidsrestherapy.com/content/6/1/11
collection DOAJ
language English
format Article
sources DOAJ
author Thabane Lehana
Smieja Marek
Odueyungbo Adefowope
Smaill Fiona
Gough Kevin
Gill John
Anderson Todd
Elston Dawn
Smith Sandy
Beyene Joseph
Lonn Eva
spellingShingle Thabane Lehana
Smieja Marek
Odueyungbo Adefowope
Smaill Fiona
Gough Kevin
Gill John
Anderson Todd
Elston Dawn
Smith Sandy
Beyene Joseph
Lonn Eva
Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study
AIDS Research and Therapy
author_facet Thabane Lehana
Smieja Marek
Odueyungbo Adefowope
Smaill Fiona
Gough Kevin
Gill John
Anderson Todd
Elston Dawn
Smith Sandy
Beyene Joseph
Lonn Eva
author_sort Thabane Lehana
title Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study
title_short Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study
title_full Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study
title_fullStr Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study
title_full_unstemmed Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study
title_sort comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in hiv: a prospective cohort study
publisher BMC
series AIDS Research and Therapy
issn 1742-6405
publishDate 2009-06-01
description <p>Abstract</p> <p>Background</p> <p>Non-invasive surrogate measures which are valid and responsive to change are needed to study cardiovascular risks in HIV. We compared the construct validity of two noninvasive arterial measures: carotid intima medial thickness (IMT), which measures anatomic disease; and brachial flow-mediated vasodilation (FMD), a measure of endothelial dysfunction.</p> <p>Methods</p> <p>A sample of 257 subjects aged 35 years or older, attending clinics in five Canadian centres, were prospectively recruited into a study of cardiovascular risk among HIV subjects. The relationship between baseline IMT or FMD and traditional vascular risk factors was studied using regression analysis. We analyzed the relationship between progression of IMT or FMD and risk factors using fixed-effects models. We adjusted for use of statin medication and CD4 count in both models.</p> <p>Results</p> <p>Baseline IMT was significantly associated with age (p < 0.001), male gender (p = 0.034), current smoking status (p < 0.001), systolic blood pressure (p < 0.001) and total:HDL cholesterol ratio (p = 0.004), but not statin use (p = 0.904) and CD4 count (p = 0.929). IMT progression was significantly associated with age (p < 0.001), male gender (p = 0.0051) and current smoking status (p = 0.011), but not statin use (p = 0.289) and CD4 count (p = 0.927). FMD progression was significantly associated with current statin use (p = 0.019), but not CD4 count (p = 0.84). Neither extent nor progression of FMD was significantly associated with any of the examined vascular risk factors.</p> <p>Conclusion</p> <p>IMT correlates better than FMD with established cardiovascular risk factors in this cohort of HIV patients. Standardization of protocols for FMD and IMT will facilitate the comparison of results across studies.</p>
url http://www.aidsrestherapy.com/content/6/1/11
work_keys_str_mv AT thabanelehana comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
AT smiejamarek comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
AT odueyungboadefowope comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
AT smaillfiona comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
AT goughkevin comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
AT gilljohn comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
AT andersontodd comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
AT elstondawn comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
AT smithsandy comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
AT beyenejoseph comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
AT lonneva comparisonofbrachialandcarotidarteryultrasoundforassessingextentofsubclinicalatherosclerosisinhivaprospectivecohortstudy
_version_ 1725440212135313408